TRDA - Entrada Therapeutics Inc
IEX Last Trade
17.74
0.240 1.353%
Share volume: 177,913
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$17.50
0.24
1.37%
Summary score
32%
Profitability
26%
Dept financing
12%
Liquidity
54%
Performance
38%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-3.95%
Return on assets
-3.45%
Return on sales
-6.62%
Return on invested capital
-42.19%
Total debt ratio
34.58%
Debt ratio change over timeo
-0.73%
Current Ratio
7.25%
Quick Ratio
7.25%
Cash Position Ratio
6.8%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
1.66%
Return on assets
1.19%
Return on sales
-2.56%
Return on invested capital
11.7%
Total debt ratio
50.72%
Debt ratio change over timeo
-1.05%
Current Ratio
2.53%
Quick Ratio
2.53%
Cash Position Ratio
2.31%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
8.72%
Return on assets
4.13%
Return on sales
35.71%
Return on invested capital
-30.41%
Total debt ratio
47.27%
Debt ratio change over time
-1.62%
Current Ratio
2.38%
Quick Ratio
2.38%
Cash Position Ratio
1.88%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.56%
Return on assets
-114.08%
Return on sales
-49.07%
Return on invested capital
-349.03%
Total debt ratio
-73.44%
Debt ratio change over time
-0.73%
Current Ratio
11.8%
Quick Ratio
11.8%
Cash Position Ratio
10.28%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TRDA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -3.95% | 13.79% | 34.47% | 7.43% |
| Return on assets | -3.45% | 2.76% | 3.15% | 5.62% |
| Return on sales | -6.62% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -42.19% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 34.58% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.73% | 308.97% | -6.99% | 1.18% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 2.53% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.53% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.31% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 15% | 36% |
| Short-term ratios | TRDA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 1.66% | 13.77% | 13.25% | 3.8% |
| Return on assets | 1.19% | 2.43% | 1.89% | 3.09% |
| Return on sales | -2.56% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 11.7% | 2.14% | 3.39% | 9.18% |
| Profitability | 38% | 69% | 66% | 77% |
| Total debt ratio | 50.72% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.05% | 46.38% | -72.08% | 1.51% |
| Dept financing | 14% | 50% | 25% | 7% |
| Current Ratio | 2.53% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.53% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.31% | 0.36% | 1.28% | 2.93% |
| Liquididy | 45% | 12% | 31% | 75% |